Bacterial adhesion to urinary tract epithelium

Bacterial adhesion to the urinary tract epithelium is a **critical initial step in the pathogenesis of urinary tract infections**. The most common causative agent is *Escherichia coli*, particularly uropathogenic strains (UPEC), which express surface structures such as **type 1 and P fimbriae** that mediate attachment to specific receptors like uroplakins on bladder epithelial cells and glycoconjugates containing sialic acid[1][2][3][4]. This adherence enables bacteria to resist urine flow, colonize the mucosa, invade epithelial cells, form intracellular biofilm-like communities, and evade host immune responses—contributing both to acute infection and recurrence through persistent reservoirs within the bladder wall[3][4]. While this process involves defined molecular interactions between bacterial adhesins and host cell receptors, "bacterial adhesion" itself is not a single molecular target but rather an interaction or biological event involving multiple molecules from both pathogen and host. Therapeutic strategies have focused on blocking these interactions using agents like mannosides that inhibit FimH-mediated binding; however, challenges remain due to biofilm-associated resistance mechanisms[2][3][4]. Note: "Bacterial adhesion to urinary tract epithelium" describes a pathogenic mechanism/process rather than an individual molecule or receptor. It cannot be classified as a canonical therapeutic target in the sense of being a discrete protein or gene product suitable for direct drug targeting. Instead, it encompasses several potential targets involved in mediating this interaction—most notably bacterial adhesins such as FimH on type 1 pili—and their corresponding host cell receptors[2][3][5].

Other names

Bacterial adherence to uroepitheliumUropathogen adhesionUPEC (Uropathogenic Escherichia coli) attachment to bladder epithelium

Inhibition of bacterial adhesins such as FimH on type 1 pili prevents binding to uroplakin receptors on bladder epithelial cells[4]